314 related articles for article (PubMed ID: 19458022)
21. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
22. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Li AJ; Scoles DR; Armstrong KU; Karlan BY
Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma.
Liu CH; Huang JD; Huang SW; Hour TC; Huang YK; Hsueh YM; Chiou HY; Lee TC; Jan KY; Chen CJ; Pu YS
J Biomed Sci; 2008 Mar; 15(2):261-9. PubMed ID: 17922225
[TBL] [Abstract][Full Text] [Related]
25. Combination of short CAG and GGN repeats in the androgen receptor gene is associated with acne risk in North East China.
Pang Y; He CD; Liu Y; Wang KB; Xiao T; Wang YK; Zhu H; Wei B; Zhao N; Jiang Y; Wei HC; Chen HD
J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1445-51. PubMed ID: 18624843
[TBL] [Abstract][Full Text] [Related]
26. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
Meng X; Lu P; Chu Z; Fan Q
Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite profile in hormonal receptor genes associated with breast cancer.
Iobagiu C; Lambert C; Normand M; Genin C
Breast Cancer Res Treat; 2006 Jan; 95(2):153-9. PubMed ID: 16317584
[TBL] [Abstract][Full Text] [Related]
28. Steroid hormones polymorphisms and cholelithiasis in Greek population.
Kitsiou-Tzeli S; Giannatou E; Spanos I; Nicolaidou P; Fretzayas A; Tzetis M; Lazaris D; Kanavakis E; Tsezou A
Liver Int; 2007 Feb; 27(1):61-8. PubMed ID: 17241382
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
30. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
[TBL] [Abstract][Full Text] [Related]
31. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.
Giguère Y; Dewailly E; Brisson J; Ayotte P; Laflamme N; Demers A; Forest VI; Dodin S; Robert J; Rousseau F
Cancer Res; 2001 Aug; 61(15):5869-74. PubMed ID: 11479228
[TBL] [Abstract][Full Text] [Related]
32. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
Li AJ; McAllister P; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor gene polymorphism and the metabolic syndrome in 60-80 years old Norwegian men.
Skjaerpe PA; Giwercman YL; Giwercman A; Svartberg J
Int J Androl; 2010 Jun; 33(3):500-6. PubMed ID: 19207614
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor alpha gene polymorphisms are associated with idiopathic premature ovarian failure.
Bretherick KL; Hanna CW; Currie LM; Fluker MR; Hammond GL; Robinson WP
Fertil Steril; 2008 Feb; 89(2):318-24. PubMed ID: 17706202
[TBL] [Abstract][Full Text] [Related]
35. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.
Leite DB; Junqueira MG; de Carvalho CV; Massad-Costa AM; Gonçalves WJ; Nicolau SM; Lopes LA; Baracat EC; da Silva ID
Steroids; 2008 Jul; 73(6):676-80. PubMed ID: 18384825
[TBL] [Abstract][Full Text] [Related]
36. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: a case-control study.
Mehdipour P; Pirouzpanah S; Kheirollahi M; Atri M
Breast J; 2011; 17(1):39-46. PubMed ID: 21159020
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
Andersson P; Varenhorst E; Söderkvist P
Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
[TBL] [Abstract][Full Text] [Related]
40. Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.
De Abreu FB; Pirolo LJ; Canevari Rde A; Rosa FE; Moraes Neto FA; Caldeira JR; Rainho CA; Rogatto SR
Anticancer Res; 2007; 27(2):1199-205. PubMed ID: 17465263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
